Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bristol-Myers Squibb Company (Bristol-Myers), a in vitro diagnostics company, has elected Lamberto Andreotti to the company as president and chief operating officer (COO), and a member of the company’s board of directors, effective March 3, 2009. Andreotti will continue to have leadership responsibility for global pharmaceuticals, technical operations and global marketing, while adding oversight of information management worldwide.
Subscribe to our email newsletter
He will continue to report to James M. Cornelius, chairman and chief executive officer.
“Lamberto’s leadership has been an integral part of our recent global commercial success, and of our transformation to a global BioPharma leader,” said Cornelius.
Andreotti has been with Bristol-Myers Squibb for 11 years. From 2002-2005, Andreotti served as a corporate senior vice president, and international president of the Worldwide Medicines Group. From 2005-2007, he served as executive vice president of Worldwide Pharmaceuticals. In May 2007, Andreotti was named executive vice president and chief operating officer.
Andreotti, Elliott Sigal, executive vice president, chief scientific officer and president, Research & Development, and Jean-Marc Huet, executive vice president and chief financial officer, continue to report to Cornelius and form the company’s executive committee.